Valion Bio, Inc. (VBIO) vs Windtree Therapeutics, Inc. (WINT)

Valion Bio, Inc. and Windtree Therapeutics, Inc. are both Biotechnology companies. Valion Bio, Inc. and Windtree Therapeutics, Inc. are of similar size ($2.4M and $2.4M). Valion Bio, Inc. grew revenue faster over the last twelve months: −49.6% against −68.4%. Across the 13 metrics below, Windtree Therapeutics, Inc. leads on 7 and Valion Bio, Inc. on 6.

Valuation

Metric VBIO WINT Biotechnology median
P/E n/m n/m 8.50
P/S 0.33 n/m 9.71
P/B 0.04 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 11.28 63.80 9.21
Earnings yield (15,509.47%) 0.00% (33.15%)
Free cash flow yield (9,619.81%) 0.00% (25.50%)

Profitability

Metric VBIO WINT Biotechnology median
Gross margin (58.09%) 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (489.30%) 1,356.23% (56.36%)
Return on assets (104.96%) (210.34%) (48.04%)
Return on invested capital (61.01%) (386.34%) 0.00%

Growth

Metric VBIO WINT Biotechnology median
Revenue growth (TTM) (49.63%) (68.35%) 6.02%
EPS growth (last fiscal year) 60.16% 97.79% 30.26%
Revenue growth, 5-year CAGR 13.18% (41.28%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric VBIO WINT Biotechnology median
Debt to equity 0.62 (1.48) 0.00
Current ratio 1.11 0.33 4.72
Net debt to EBITDA 0.79 0.03 0.96

Dividend

Metric VBIO WINT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric VBIO WINT Biotechnology median
Market cap 2.39m 2.35m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack